MedTrace Logo

Medical Therapies for Chronic Post-Traumatic Headaches

NCT00862095 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2013-04-23

No results posted yet for this study

Summary

To determine if propranolol, amitriptyline, or topiramate decreases headache frequency in patients with chronic post-traumatic headaches.

Conditions

Interventions

DRUG

Placebo

Every month for 3 months

DRUG

Propranolol

target does 80 mg per day for 3 months

DRUG

Amitriptyline

Target does of 50 mg per day for 3 months

DRUG

Topiramate

Target dose 100 mg a day for 3 months

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    collaborator FED

  • Madigan Army Medical Center

    lead FED

Principal Investigators

  • Jay Erickson, MD · Madigan Army Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00862095 on ClinicalTrials.gov